We are live on ! Find out more
DMTX

Dimension Therapeutics, Inc
DMTX

Delisted

DMTX was delisted on the 6th of November, 2017.

Back to rankings

52 hedge funds and large institutions have $129M invested in Dimension Therapeutics, Inc in 2016 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 3

200% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 7

30% more funds holding

Funds holding: 40 → 52 (+12)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

24% less capital invested

Capital invested by funds: $169M → $129M (-$40.3M)

Holders
52
Holders Change
+12
Holders Change %
+30%
% of All Funds
1.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
21
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity International
Fidelity International
Bermuda
+$12.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.65M
3
BFA
BlackRock Fund Advisors
California
+$1.31M
4
Goldman Sachs
Goldman Sachs
New York
+$736K
5
SIM
Spark Investment Management
New York
+$466K

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$16M
2
Jennison Associates
Jennison Associates
New York
-$5.83M
3
FCMI
Foresite Capital Management III
California
-$770K
4
PHS
PFM Health Sciences
California
-$450K
5
JP Morgan Chase
JP Morgan Chase
New York
-$359K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$173K +$141K +18,506 +181%
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$154K +$104K +13,610 +113%
ARTA
28
A.R.T. Advisors
New York
$134K +$171K +22,497 New
BCM
29
Bridgeway Capital Management
Texas
$128K +$163K +21,400 New
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$124K +$36.8K +4,827 +30%
HCM
31
Highbridge Capital Management
New York
$123K +$157K +20,573 New
TA
32
Teachers Advisors
New York
$115K +$101K +13,283 +224%
PIM
33
Partner Investment Management
California
$89K -$11.7K -1,539 -9%
CS
34
Credit Suisse
Switzerland
$84K +$108K +14,156 New
Charles Schwab
35
Charles Schwab
California
$79K – – –
NI
36
Numeric Investors
Massachusetts
$75K +$95.5K +12,542 New
NFA
37
Nationwide Fund Advisors
Ohio
$45K +$26K +3,416 +84%
AIG
38
American International Group
New York
$42.2K +$29.2K +3,837 +120%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$40K – – –
Morgan Stanley
40
Morgan Stanley
New York
$37K +$45.6K +5,984 +3,343%
BlackRock
41
BlackRock
New York
$32K +$39.6K +5,207 +4,568%
BA
42
BlackRock Advisors
Delaware
$20K +$11.8K +1,545 +88%
PCM
43
Prelude Capital Management
New York
$18K +$22.8K +3,000 New
Deutsche Bank
44
Deutsche Bank
Germany
$11K +$7.83K +1,028 +122%
UBS Group
45
UBS Group
Switzerland
$11K +$10K +1,319 +231%
Bank of America
46
Bank of America
North Carolina
$11K +$14.3K +1,874 New
SO
47
STRS Ohio
Ohio
$10K – – –
Citigroup
48
Citigroup
New York
$7K -$26.1K -3,423 -73%
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$5K -$7.54K -990 -56%
MA
50
MUFG Americas
New York
$4K +$5.03K +660 New
1
2
3

DMTX Hedge Fund Activity: Q2 2016 in Review

52 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Dimension Therapeutics, Inc (DMTX) for Q2 2016, worth a combined $129M — down 24% from $169M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new DMTX positions and 3 closed out — a net gain of 12 holders — while 21 added to existing stakes and 7 trimmed.

The largest buyer was Fidelity International, opening a new position worth an estimated $12.9M. The largest seller was Fidelity Investments, cutting an estimated $16M.

  • 52 institutional investors held Dimension Therapeutics, Inc (DMTX) as of Q2 2016, up from 40 in Q1 2016.
  • Funds reported $129M of Dimension Therapeutics, Inc stock for Q2 2016, down 24% quarter-over-quarter.
  • 15 funds opened new Dimension Therapeutics, Inc positions in Q2 2016 and 3 closed out, a net change of +12 holders.
  • The largest Dimension Therapeutics, Inc buyer in Q2 2016 was Fidelity International, an estimated $12.9M added.
  • The largest Dimension Therapeutics, Inc seller in Q2 2016 was Fidelity Investments, an estimated $16M sold.

Based on aggregated 13F filings for Q2 2016.